Provider: Wright Reports
NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.
Navamedic ASA announces FY 2014 financial guidance
Navamedic ASA:Expects continued sales growth in H2 2014, both organically and through the addition of new products.
Latest Key Developments in Pharmaceuticals
- AstraZeneca PLC announces FDA approval for MOVANTIK (naloxegol) Tablets
- Wockhardt Ltd approves scheme of amalgamation
- Regeneron Pharmaceuticals Inc announces EYLEA (aflibercept) injection receives FDA breakthrough therapy designation for diabetic retinopathy in patients with diabetic macular edema
- Aurobindo Pharma Ltd receives USFDA Approval for Amoxicillin
- Share this
- Digg this